Tag:

social media

Latest Headlines

Latest Headlines

U.K. watchdogs hope to tap social media for drug-safety purposes

Now, it's U.K. drug regulators who are devising plans to eavesdrop on social media. But unlike the FDA, which plans to monitor the world of online sharing to see whether its communications are hitting their targets, the Medicines and Healthcare Products Regulatory Agency plans to search for drug safety info.

Biopharma searching for right balance in addressing social media use by trial participants

A Wall Street Journal feature this week on researchers' long-standing concerns about the consequences of patients talking about clinical trials online digs into how biopharma companies are tapping technology to counter concerns about unblinding and manipulating inclusion/exclusion criteria.

Pfizer amps up its 'Get old' campaign with more content, more social media

What's #FOGO? Hint: Many of us have it. Another hint: Pfizer wants people to talk about it.

FDA garbles social media education, but social media discipline is clear enough

The FDA may be having problems handing down its social media commandments. But it's playing enforcer just the same.

In social media, what's easier to grasp--an FDA webinar or an FDA warning?

The FDA may be having problems handing down its social media commandments. But it's playing enforcer just the same.

The FDA should step up its own social-media action, NEJM researchers say

The FDA has given drugmakers some social media advice. Now, researchers have some online advice for the FDA.

Experts warn FDA Twitter guidance will silence social conversation

Having had a week to mull over the FDA's latest batch of social media guidance, some observers have concluded the agency is making a blunt statement to brand managers: Don't use Twitter.

FDA's social media translation for brand managers: Don't use Twitter

Any brand managers eager to jump into Twitter as soon as the FDA gave the go-ahead? No such luck. Last week's social media guidance on risk disclosures may have cleared up some of the regulatory fog, but in this case, clarity isn't a positive.

FDA speaks on social media: No benefits without risks, even on Twitter

The FDA has unveiled two more pieces of its social media guidance. 

Big Pharma sees danger, not safety, in FDA's new social media guidance

The FDA may have released its latest social media guidance in January, but judging by the industry's reaction, it appears some of pharma's marketers don't have any more answers than they did before. In fact, they have more questions.